|
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma |
|
|
|
Titel: |
A first-in-human, phase 1a dose-escalation study of the selective MEK1/2 inhibitor FCN-159 in patients with advanced NRAS-mutant melanoma |
Auteur: |
Mao, Lili Guo, Jun Zhu, Lingjun Jiang, Yu Yan, Wangjun Zhang, Jian Hui, Ai-Min Yang, Yuchen Diao, Lei Tan, Yan Zhao, Han Jiang, Yiqian Wu, Zhuli Si, Lu |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 175 () nr. C pagina's 125-135 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|